Oksana Lekarev, DO

Highlights

1
Journal of clinical research in pediatric endocrinology · 2023
CCCorinne Catarozoli DPDix Phillip Poppas OLOksana Lekarev
PMID: 37470306PMCID: PMC10683541DOISenior author8 citations
2
Hormone research in paediatrics · 2022
OLOksana Lekarev
PMID: 35220302DOISenior author5 citations
3
Pediatrics · 2022
VKVikash K. Modi CMChristopher Mccord Cunniff OLOksana Lekarev
PMID: 35773519DOISenior author

19

3

1 study

PI
A Phase 4 Observational Study of Clinical Outcomes in Real-World Practice Settings for Pediatric and Adult Patients with Classic Congenital Adrenal Hyperplasia (CAH) Following or During Participation in Phase 3 CRENESSITYÂ® (crinecerfont) Trials
Neurocrine Biosciences INC · OPEN TO ACCRUAL (as of 2026)

Completed & closed trials (2)

PI
Mental Health in Children with Congenital Adrenal Hyperplasia and their Caregivers
Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2023)
PI
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects With Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment
PHASE3 · Neurocrine Biosciences INC · CLOSED TO ACCRUAL (as of 2022)
Congenital Adrenal Hyperplasia
NCT04490915

Neurocrine Biosciences INC